Arcellx (ACLX) Amortizatization of Intangibles (2021 - 2025)

Arcellx's quarterly Amortizatization of Intangibles came in at $1.2 million in Q4 2025, down 65.13% year-on-year from $3.6 million in Q4 2024, and down 81.77% quarter-over-quarter from $6.8 million in Q3 2025.

Arcellx has reported Amortizatization of Intangibles for 5 years, with the latest figure at $1.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 65.13% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $8.4 million (down 45.38% YoY), and the FY2025 full-year result was $8.4 million, down 45.38% from the prior year.
  • Amortizatization of Intangibles for Q4 2025 stood at $1.2 million, down from $6.8 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $6.8 million in Q3 2025, with the low at -$1.4 million in Q2 2023.
  • Average Amortizatization of Intangibles over 5 years is $2.1 million, with a median of $1.2 million recorded in 2025.
  • Peak annual rise in Amortizatization of Intangibles reached 1898.18% in 2023, while the deepest fall reached 2056.94% in 2023.
  • Tracing ACLX's Amortizatization of Intangibles over 5 years: stood at -$150000.0 in 2021, then sank by 90.0% to -$285000.0 in 2022, then surged by 1483.86% to $3.9 million in 2023, then decreased by 9.53% to $3.6 million in 2024, then sank by 65.13% to $1.2 million in 2025.
  • The last three Amortizatization of Intangibles figures came in at $1.2 million (Q4 2025), $6.8 million (Q3 2025), and $188000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 13,267.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Arcellx 6.48 Bn 6.48 Bn - 1.24 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.24 Mn
Dec 31, 2025 1.24 Mn
Sep 30, 2025 6.83 Mn
Sep 30, 2025 6.83 Mn
Jun 30, 2025 188,000.00
Jun 30, 2025 188,000.00
Mar 31, 2025 186,000.00
Mar 31, 2025 186,000.00
Dec 31, 2024 3.57 Mn
Dec 31, 2024 3.57 Mn
Sep 30, 2024 3.40 Mn
Sep 30, 2024 3.40 Mn
Jun 30, 2024 5.58 Mn
Jun 30, 2024 5.58 Mn
Mar 31, 2024 2.90 Mn
Mar 31, 2024 2.90 Mn
Dec 31, 2023 3.94 Mn
Dec 31, 2023 3.94 Mn
Sep 30, 2023 6.54 Mn
Sep 30, 2023 6.54 Mn
Jun 30, 2023 -1.41 Mn
Jun 30, 2023 -1.41 Mn
Mar 31, 2023 1.98 Mn
Mar 31, 2023 1.98 Mn
Dec 31, 2022 -285,000.00
Dec 31, 2022 -285,000.00
Sep 30, 2022 1.23 Mn
Sep 30, 2022 1.23 Mn
Jun 30, 2022 72,000.00
Jun 30, 2022 72,000.00
Mar 31, 2022 -110,000.00
Mar 31, 2022 -110,000.00
Dec 31, 2021 -150,000.00
Dec 31, 2021 -150,000.00